Le Lézard
Classified in: Science and technology, Business

OKX Wallet Now Integrated with Avalon Finance


SINGAPORE, July 29, 2024 /PRNewswire/ -- OKX, a global Web3 technology company, has issued updates for July 29, 2024.

OKX Wallet Now Integrated with Avalon Finance

OKX Wallet is now integrated with Avalon Finance, the leading decentralized lending platform within the BTC ecosystems.

Through this integration, OKX Wallet's eligible users can effortlessly access Avalon Finance's decentralized lending protocol and CeDeFi lending solutions via web extension.

Connecting to Avalon Finance is straightforward: users need to select 'Connect Wallet' and choose 'OKX Wallet,' then log in through the web extension available on Chrome or Firefox.

Avalon Finance is committed to providing innovative and efficient financial solutions across multiple blockchain ecosystems, including Arbitrum, BNB Chain, Bitlayer, CoreDAO, Ethereum and Merlin. The platform's architecture is designed to adapt to the evolving needs of its users, maintaining high standards of security and transparency.

To learn more, visit OKX's Support Center.

About OKX

OKX is a leading global crypto exchange and innovative Web3 company. Trusted by more than 50 million global users, OKX offers a secure and trustworthy platform that provides responsible crypto traders with innovative tools to access the world of crypto.

As a global brand and top partner of Manchester City FC and McLaren Racing, OKX uses Web3 technology to redefine how fans connect with their favorite teams. Recent examples include its Unseen City Shirts and Race Rewind digital collectible campaigns, which offer fans real-world benefits like exclusive match-day and trackside experiences. As the Presenting Partner of Tribeca Festival, OKX also empowers artists and creators through Web3.

In line with its "on-chain, any chain" philosophy, OKX contributes to the growth of the Web3 ecosystem via its secure, interoperable and self-custody enabled OKX Wallet. OKX Wallet is a user-friendly gateway to the on-chain world, connecting to over 100 blockchains, 10,000 dApps, 170+ DeFi protocols, 300,000 tokens and 490+ decentralized exchanges (DEXs).

OKX is committed to transparency and security, and publishes its Proof of Reserves monthly to build trust. It is also dedicated to expanding its educational resources through OKX Learn, making digital assets accessible and understandable for a broader audience.

To learn more about OKX, download our app or visit: okx.com

Disclaimer

This announcement is provided for informational purposes only. It is not intended to provide any investment, tax, or legal advice, nor should it be considered an offer to purchase, sell, hold or offer any services relating to digital assets. Digital assets, including stablecoins, involve a high degree of risk, can fluctuate greatly, and can even become worthless.

SOURCE OKX


These press releases may also interest you

at 16:20
bluebird bio, Inc. ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ("Ayrmid") to acquire bluebird for an upfront cash payment of $4.50 per share and a one-time...

at 16:14
The official brand behind Arialief, a product developed under Bioventra's portfolio of advanced formulations, has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports indicate that...

at 16:10
Vertex Pharmaceuticals Incorporated today announced several updates on the Company's type 1 diabetes (T1D) portfolio. VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 (cells + device) study and the...

at 16:10
Boxlight Corporation ("Boxlight" or the "Company"), a leading provider of interactive technology solutions, today announced the Company's financial results for the fourth quarter and full year ended December 31, 2024. Financial and Operational...

at 16:08
Orases, a custom software solutions company, recently announced an expansion of their service offerings to include AI agent development services. This strategic expansion represents a significant advancement in their artificial intelligence...

at 16:07
Curis, Inc. , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will report its fourth quarter 2024 financial and operating results on...



News published on and distributed by: